Involvement of the Na+,K+-ATPase and its inhibitors in cardiovascular diseases

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.8, Iss.1, 1998-01, pp. : 39-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation of Na+/K+-ATPase by Estradiol and IGF-1 in Cardio-Metabolic Diseases

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1551-1561

Bentham Science Publishers

Access to resources Recommend Favorite

Na+/K+ ATPase Inhibitors in Cancer

Current Drug Targets, Vol. 15, Iss. 10, 2014-09 ,pp. : 988-1000

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of sarcoplasmic reticulum in changing intracellular calcium due to Na⁺/K⁺-ATPase inhibition in cardiomyocytes

By Saini-Chohan Harjot K. Goyal Ramesh K. Dhalla Naranjan S.

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 7, 2010-07 ,pp. : 702-715

NRC Research Press

Access to resources Recommend Favorite

Modulators of Na/K-ATPase: a patent review

By Wang Hua-Yu Leo O’Doherty George A

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 6, 2012-06 ,pp. : 587-605

Informa Healthcare

Access to resources Recommend Favorite

Effects of Chronic and Acute Ethanol Exposure on Renal (Na+K)-ATPase in the Rat

By Rodrigo R. Thielemann L.

General Pharmacology, Vol. 29, Iss. 5, 1997-11 ,pp. : 719-723

Elsevier

Access to resources Recommend Favorite